PROF. DR. MEHMET ÖZTÜRK'S SPEECH ON BIOTECHNOLOGICAL DRUGS FOR THE EKONOMIST MAGAZINE
The Biotechnological Drugs supplement of the Ekonomist magazine released on 4 November 2018 featured the views of IBG Director Prof. Dr. Mehmet Öztürk on the importance of new generation biotechnological drugs, Turkey’s position in the world in terms of biotechnological drug production and IBG’s leading ventures on the production of new generation biological drugs. Prof. Dr. Mehmet Ozturk stated that IBG continues to work in an organised and coordinated manner in order to decrease Turkey’s foreign dependency on new generation biotechnological drugs, and that in addition to the biotechnological drug production project IBG is currently implementing, work is now underway for three new molecules. Moreover, Prof. Dr. Mehmet Ozturk also underlined that the equipment and personnel required to be able to carry out the four critical steps of drug production within IBG will be complete by the end of 2018, and that by the middle of 2019, it will be possible to produce a capacity of 200 liters of these drugs as well as provide training on this production. Click here for further details: http://ieis.org.tr/ieis/tr/biyoteknolojikilaclar042018#16